2014
Tobacco Dependence, the Most Important Cardiovascular Risk Factor: Treatment in the Czech Republic
KRÁLÍKOVÁ, E.; A. KMEŤOVÁ; L. ŠTĚPÁNKOVÁ; K. ZVOLSKÁ; V. FELBROVÁ et al.Základní údaje
Originální název
Tobacco Dependence, the Most Important Cardiovascular Risk Factor: Treatment in the Czech Republic
Autoři
KRÁLÍKOVÁ, E.; A. KMEŤOVÁ; L. ŠTĚPÁNKOVÁ; K. ZVOLSKÁ; V. FELBROVÁ; S. KULOVANÁ; Zbyněk BORTLÍČEK; Milan BLAHA a K. FRASER
Vydání
Physiological Research, Prague, Institute of Physiology, Academy of Sciences of the Czech Republic, 2014, 0862-8408
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30105 Physiology
Stát vydavatele
Česká republika
Utajení
není předmětem státního či obchodního tajemství
Impakt faktor
Impact factor: 1.293
Označené pro přenos do RIV
Ano
Kód RIV
RIV/00216224:14110/14:00078320
Organizační jednotka
Lékařská fakulta
UT WoS
Klíčová slova anglicky
Tobacco dependence; Smoking cessation; Cardiovascular risk
Štítky
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 14. 1. 2015 14:42, Soňa Böhmová
Anotace
V originále
Smoking is the most important cardiovascular (CV) risk factor. Stopping smoking halves the CV risk. Every clinician should provide a brief intervention with smokers. Intensive treatment should be available to those who need it. There are 37 Centers for Tobacco Dependence in the Czech Republic, which offer treatment including a psychobehavioral intervention and pharmacotherapy (varenicline, nicotine, bupropion). Czech physicians, pharmacists and nurses are regularly educated about smoking cessation. We describe the results of intensive treatment offered by our centers. Treatment includes screening (1 h), an intervention (2 h), and follow-up visits during the next 12 months. Among 3532 patients, 34.3 % had CO-validated abstinence at 12-months (including 489 patients who attended the screening visit + only the 12-month follow up visit). Among patients who underwent the intervention, the abstinence rate was 38.2 %. The majority of patients who underwent the intervention (N = 2470) used some form of pharmacotherapy. After one year, the abstinence rate was 43.4 %, compared to 15.9 % (N= 573) without pharmacotherapy. Only 28 % of patients came on the recommendation of a physician. Despite the decrease in CV risk following smoking cessation and the effectiveness of treatment, centers are underutilized.